Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
about
Anticoagulation Management and Monitoring during Pediatric Extracorporeal Life Support: A Review of Current IssuesExpression, purification, and mass spectrometric analysis of 15N, 13C-labeled RGD-hirudin, expressed in Pichia pastoris, for NMR studiesBivalirudin: a review.The management of heparin-induced thrombocytopenia.Direct thrombin inhibitors.The management of suspected heparin-induced thrombocytopenia in US hospitals.Protease-resistant peptide ligands from a knottin scaffold library.Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential.A few immobilized thrombins are sufficient for platelet spreadingBivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.New anticoagulants and antiplatelet agents: a primer for the clinical gastroenterologist.Aptamer RA36 inhibits of human, rabbit, and rat plasma coagulation activated with thrombin or snake venom coagulases.Medical leech therapy in plastic reconstructive surgery.In silico designing of a new cysteine analogue of hirudin variant 3 for site specific PEGylation.Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics.Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC-MS/MS: Method development, validation and application to pharmacokinetics.Toxicology Assessment of a Dual-Function Peptide 5rolGLP-HV in Mice.Multifunctional mussel-inspired copolymerized epigallocatechin gallate (EGCG)/arginine coating: the potential as an ad-layer for vascular materials.Evaluation of drug release from paclitaxel + hirudin-eluting balloons and the resulting vascular reactivity in healthy pigs
P2860
Q26742088-87EF0FC1-E3CC-4791-825A-0C712CDE4E8AQ31081745-D30F084D-E944-4C97-9EF5-7D59392E3E08Q33367230-E6916028-E469-4791-935A-11C8A79616CEQ33371013-6D1A2D7E-2D01-40E1-9B62-67A783729E07Q33393692-C6236E38-EA97-45F7-952F-4A8F687A8CA3Q33402813-1F6F817F-C83F-47EB-8C14-EEDC441FB935Q33912692-D99A2704-3777-488D-973E-BD5A88011B38Q33948546-727B4486-59B5-431D-8827-AE56DADB829AQ34800954-4DA86B8C-47A4-41B4-9F89-91BB4844784CQ36953866-04A62C7D-141E-4745-B7EB-9CCD8000513CQ38176801-C29E7BC1-E367-4ACE-A8A7-CE657A9550CEQ38310562-4797FA82-DE32-4334-9B66-D51E5F869602Q38571397-F29C91B6-943C-49F9-83D6-A1A349B703FEQ41951405-65704AD4-5234-41BC-86DE-29F1267AF0C8Q42821688-D5A99827-CD5D-4695-B720-5EE74EF629CBQ50062959-FB462E05-3F20-4020-94C1-BC7FF1042B1AQ51677840-5D7A7F29-4F64-4B59-9BEA-1DFDA0177B9CQ55039764-8C263080-AD67-45E6-A7DB-E2B4B551A117Q58710785-D5A585BD-0156-40CB-8464-BCE5F5230582
P2860
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@ast
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@en
type
label
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@ast
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@en
prefLabel
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@ast
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@en
P1476
Bivalent direct thrombin inhibitors: hirudin and bivalirudin.
@en
P304
P356
10.1016/J.BEHA.2004.02.002
P577
2004-03-01T00:00:00Z